Long-term lessons from MATCH01 macrophage therapy in cirrhosis.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 42392049.
- Also identified by DOI 10.1016/j.stem.2026.05.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a long-term follow-up of a phase 1/2 clinical trial, Stuart Forbes and colleagues demonstrate that autologous macrophage therapy improves transplantation-free survival in patients with liver cirrhosis. These findings show the translational value of autologous macrophage-based regenerative therapy for advanced liver diseases.
Medical subject headings
- Liver Cirrhosis
- Macrophages